Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera MRMHR

ABSTRACT: Targeted mass spectrometric assays for the 22 proteins in a second test cohort containing 19 COVID-19 patients

Dataset imported into MassIVE from https://www.iprox.org/page/project.html?id=IPX0002171000 on 05/30/20

INSTRUMENT(S): TripleTOF 6600

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

SUBMITTER: Tiannan Guo

PROVIDER: MSV000085515 | MassIVE | Sat May 30 12:33:00 BST 2020

SECONDARY ACCESSION(S): PXD019232

REPOSITORIES: MassIVE

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Publications

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera.

Shen Bo B Yi Xiao X Sun Yaoting Y Bi Xiaojie X Du Juping J Zhang Chao C Quan Sheng S Zhang Fangfei F Sun Rui R Qian Liujia L Ge Weigang W Liu Wei W Liang Shuang S Chen Hao H Zhang Ying Y Li Jun J Xu Jiaqin J He Zebao Z Chen Baofu B Wang Jing J Yan Haixi H Zheng Yufen Y Wang Donglian D Zhu Jiansheng J Kong Ziqing Z Kang Zhouyang Z Liang Xiao X Ding Xuan X Ruan Guan G Xiang Nan N Cai Xue X Gao Huanhuan H Li Lu L Li Sainan S Xiao Qi Q Lu Tian T Zhu Yi Y Liu Huafen H Chen Haixiao H Guo Tiannan T

Cell 20200528 1

Early detection and effective treatment of severe COVID-19 patients remain major challenges. Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals. We then trained a machine learning model using proteomic and metabolomic measurements from a training cohort of 18 non-severe and 13 severe patients. The model was validated using 10 independent patients, 7 of which were correctly classified. Targeted proteomics and metabolomics assays were employe ...[more]

PMID: 32492406

Similar Datasets

Urine proteomics profiling of the COVID-19

Project description:Urine proteomics profiling from the mild and severe COVID-19 patients<ul><li>Dataset imported into MassIVE from <a href="https://www.iprox.org/page/project.html?id=IPX0002166000">https://www.iprox.org/page/project.html?id=IPX0002166000</a> on 05/30/20</li></ul>

2020-05-30 | MSV000085516 | MassIVE

GNPS - Proteomic and Metabolomic Characterization of COVID-19 Patient Sera MRMHR

Project description:Targeted mass spectrometric assays for the 22 proteins in a second test cohort containing 19 COVID-19 patients<ul><li>Dataset imported into MassIVE from <a href="https://www.iprox.org/page/project.html?id=IPX0002171000">https://www.iprox.org/page/project.html?id=IPX0002171000</a> on 05/30/20</li></ul>

2020-05-30 | MSV000085515 | GNPS

Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

Project description:Early detection and effective treatment of severe COVID-19 patients remain major challenges. Here, we performed proteomic and metabolomic profiling of sera from 46 COVID-19 and 53 control individuals. We then trained a machine learning model using proteomic and metabolomic measurements from a training cohort of 18 non-severe and 13 severe patients. The model was validated using ten independent patients, seven of which were correctly classified. Targeted proteomics and metabolomics assays were employed to further validate this molecular classifier in a second test cohort of 19 new COVID-19 patients, leading to 16 correct assignments. We identified molecular changes in the sera of COVID-19 patients compared to other groups implicating dysregulation of macrophage, platelet degranulation and complement system pathways, and massive metabolic suppression. This study revealed characteristic protein and metabolite changes in the sera of severe COVID-19 patients, which might be used in selection of potential blood biomarkers for severity evaluation.<ul><li>Dataset imported into MassIVE from <a href="https://www.iprox.org/page/project.html?id=IPX0002106000">https://www.iprox.org/page/project.html?id=IPX0002106000</a> on 05/29/20</li></ul>

2020-05-29 | MSV000085507 | MassIVE

GNPS - Proteomic and Metabolomic Characterization of COVID-19 Patient Sera

2020-05-29 | MSV000085507 | GNPS

A Comparative Study of Human Testes and Epididymis through the Proteomics and RNA-seq Methods

Project description:A Comparative Study of Human Testes and Epididymis through the Proteomics and RNA-seq Methods <ul><li>Dataset imported into MassIVE from <a href="https://www.iprox.cn/page/project.html?id=IPX0003098000">https://www.iprox.cn/page/project.html?id=IPX0003098000</a> on 12/10/21</li></ul>

2021-12-13 | MSV000088554 | MassIVE

System Suitability (CompRef) Study: Human-in-mouse xenograft breast cancer tumor samples

Project description:The objective of the "System Suitability (CompRef) Study" was to validate mass spectrometry protocols used at each Proteome Characterization Center (PCC). <ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S010">https://cptac-data-portal.georgetown.edu/cptac/s/S010</a> on 10/22/19</li></ul>

2019-10-23 | MSV000084497 | MassIVE

Time-Dependent Proteome Study: Human-in-mouse xenograft breast cancer tumor samples (0, 5, 30, 60 min)

Project description:The objective of the Time-Dependent Proteome Study was to evaluate changes in the proteome and phosphoproteome when there is a delay in freezing tissues following sample (tumor) excision. The biospecimens used are from human-in-mouse breast cancer tumor samples. <a href="http://www.ncbi.nlm.nih.gov/pubmed/24719451" target="_blank">Ref: Mertins P et al., (2014) Mol Cell Proteomics, Apr 9. E-Publication</a><ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S011">https://cptac-data-portal.georgetown.edu/cptac/s/S011</a> and <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S012">https://cptac-data-portal.georgetown.edu/cptac/s/S012</a> on 08/29/19</li></ul>

2019-08-30 | MSV000084260 | MassIVE

Time-Dependent Proteome Study: Human ovarian cancer tumor samples (0, 5, 30, 60 min)

Project description:The objective of the Time-Dependent Proteome Study, was to evaluate changes in the proteome and phosphoproteome when there is a delay in freezing tissues following sample (tumor) excision. The biospecimens used are from patient-derived ovarian cancer tumors. <a href="http://www.ncbi.nlm.nih.gov/pubmed/24719451" target="_blank">Ref: Mertins P et al., (2014) Mol Cell Proteomics, Apr 9. E-Publication</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/25670172" target="_blank">Ref: Gajadhar, A.S., et al., (2015) Cancer Res. Apr 1;75(7):1495-503. Epub 2015 Feb 10.</a><ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S013">https://cptac-data-portal.georgetown.edu/cptac/s/S013</a> on 11/05/18</li></ul>

2018-11-05 | MSV000083107 | MassIVE

Time-Dependent Proteome Study: Human colorectal tumor samples (0, 10, 30, 60 min)

Project description:The objective of the Time-Dependent Proteome Study was to evaluate changes in the proteome and phosphoproteome when there is a delay in freezing tissues following sample (tumor) excision. The biospecimens used are from snap-frozen colon adenocarcinoma core biopsy punches. <a href="http://www.ncbi.nlm.nih.gov/pubmed/25670172" target="_blank">Ref: Gajadhar, A.S., et al., (2015) Cancer Res. Apr 1;75(7):1495-503. Epub 2015 Feb 10.</a><ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S023">https://cptac-data-portal.georgetown.edu/cptac/s/S023</a> on 08/28/19</li></ul>

2019-08-28 | MSV000084243 | MassIVE

CPTAC, TCGA Breast Cancer Proteome Study Comparison and Reference Samples (CompRef)

Project description:Comparison and Reference (CompRef) Samples, initially characterized in the <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S010" target="_blank">System Suitability Study</a>, were analyzed along with the TCGA Breast Cancer tumor samples. These 5 iTRAQ experiments include proteome and phosphoproteome interrogation of both the P5 (basal) and P6 (luminal) human-in-mouse xenograft breast carcinoma pooled samples. The CompRef experiments were intercalated between the TCGA Breast Cancer experiments to monitor the consistency of laboratory protocols and mass spectrometry instrument performance.<ul><li>Dataset imported into MassIVE from <a href="https://cptac-data-portal.georgetown.edu/cptac/s/S018">https://cptac-data-portal.georgetown.edu/cptac/s/S018</a> on 08/25/19</li></ul>

2019-08-25 | MSV000084233 | MassIVE

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data